Exact Sciences (EXAS) Notes Payables (2018 - 2024)

Exact Sciences (EXAS) has 5 years of Notes Payables data on file, last reported at $249.2 million in Q4 2024.

• Notes Payables for Q4 2024 came in at $249.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $249.2 million (changed N/A YoY), and the FY2024 annual result was $249.2 million, changed N/A from the prior year.
• Notes Payables held at $249.2 million in Q4 2024 per EXAS's latest filing, from $249.0 million in the prior quarter.
• Over five years, Notes Payables peaked at $313.0 million in Q2 2021 and troughed at $1.3 million in Q2 2020.
• A 3-year average of $121.8 million and a median of $24.6 million in 2020 frame the typical range for Notes Payables.
• On a YoY basis, Notes Payables climbed as much as 23627.14% in 2021 and fell as far as 94.63% in 2021.
• A 3-year view of Notes Payables shows it stood at $1.3 million in 2020, then changed by 0.0% to $1.3 million in 2021, then soared by 18789.54% to $249.2 million in 2024.
• Business Quant data shows EXAS's Notes Payables at $249.2 million in Q4 2024, $249.0 million in Q3 2024, and $248.9 million in Q2 2024.